6.150USD-3.00%Mkt Cap: 169.34M USDP/E: —Last update: 2026-06-01
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap169.34M USD
Enterprise Value171.99M USD
Revenue (TTM)64.68M USD
Gross Profit40.93M USD
Net Income (TTM)-11.43M USD
Revenue/Share2.520 USD
Last Price6.150 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-105.17
PEG—
EV/EBITDA-85.10
EV/Revenue2.66
P/S2.69
P/B5.59
EPS (TTM)-0.37
EPS (Forward)-0.06
52W Range
4.31035% of range9.555
52W High9.555 USD
52W Low4.310 USD
Profitability
Gross Margin66.17%
Oper. Margin-9.35%
EBITDA Margin-3.13%
Profit Margin-18.48%
ROE-35.89%
ROA-12.08%
Growth
Revenue Growth21.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.44M USD
CapEx (TTM)—
FCF Margin-5.10%
FCF Yield-1.95%
Net Debt-1.75M USD
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.80
Current Ratio1.72
Quick Ratio1.38
Book Value/Sh1.128 USD
Cash/Share0.9890 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)13.50 USD
Target Range12.00 USD – 16.00 USD
# Analysts4
Ownership
Shares Out.21.53M
Float14.86M
Insiders32.31%
Institutions55.68%
Short Interest
Short Ratio14.5d
Short % Float22.88%
Short % Out.12.59%
Shares Short3.47M
Short (prev mo.)3.72M
Technical
SMA 505.500 (+11.8%)
SMA 2007.217 (-14.8%)
Beta1.03
S&P 52W Chg27.94%
Avg Vol (30d)232.17K
Avg Vol (10d)322.77K
Technical Indicators
RSI (14)64.5
MACD0.2087
MACD Signal0.1364
MACD Hist.+0.0723
BB Upper6.819 USD
BB Middle5.699 USD
BB Lower4.579 USD
BB Width39.31%
ATR (14)0.3710 USD
Vol Ratio (20d)0.37x